scholarly article | Q13442814 |
P356 | DOI | 10.1021/BI200771M |
P698 | PubMed publication ID | 21682276 |
P2093 | author name string | Katsumi Matsuzaki | |
Masaru Hoshino | |||
Takahiro Yamaguchi | |||
Saori Fukunaga | |||
Keisuke Ikeda | |||
P433 | issue | 29 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | protein aggregation | Q7251455 |
P304 | page(s) | 6433-6440 | |
P577 | publication date | 2011-06-29 | |
P1433 | published in | Biochemistry | Q764876 |
P1476 | title | Mechanism of amyloid β-protein aggregation mediated by GM1 ganglioside clusters. | |
P478 | volume | 50 |
Q89947927 | Amylin and pramlintide modulate γ-secretase level and APP processing in lipid rafts |
Q36437225 | Amyloid-β adopts a conserved, partially folded structure upon binding to zwitterionic lipid bilayers prior to amyloid formation |
Q48449858 | Cholesterogenic genes expression in brain and liver of ganglioside-deficient mice. |
Q64072246 | Conformational Change of Amyloid-β 40 in Association with Binding to GM1-Glycan Cluster |
Q33946695 | Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease. |
Q38219667 | Emergent properties arising from the assembly of amphiphiles. Artificial vesicle membranes as reaction promoters and regulators |
Q36270027 | Europium as an inhibitor of Amyloid-β(1-42) induced membrane permeation |
Q38436531 | GM1 ganglioside and Alzheimer's disease |
Q38853822 | Gangliosides of the Vertebrate Nervous System |
Q46596148 | Glycolipid Crosslinking Is Required for Cholera Toxin to Partition Into and Stabilize Ordered Domains |
Q39243274 | Impact of GM1 on Membrane-mediated Aggregation/Oligomerization of β-amyloid: Unifying View |
Q48089406 | Interaction Between Luteinizing Hormone-Releasing Hormone and GM1-Doped Cholesterol/Sphingomyelin Vesicles: A Spectroscopic Study. |
Q92423135 | Lipid and Lipid Raft Alteration in Aging and Neurodegenerative Diseases: A Window for the Development of New Biomarkers |
Q36052691 | Lipid rafts and Alzheimer's disease: protein-lipid interactions and perturbation of signaling |
Q36517535 | Membrane roughness as a sensitive parameter reflecting the status of neuronal cells in response to chemical and nanoparticle treatments |
Q41682538 | Monosialoganglioside-GM1 triggers binding of the amyloid-protein salmon calcitonin to a Langmuir membrane model mimicking the occurrence of lipid-rafts |
Q50917387 | On Electrochemical Methods for Determination of Protein-Lipid Interaction. |
Q39176826 | Partitioning and confinement of GM1 ganglioside induced by amyloid aggregates. |
Q36425070 | Proteomic Analysis of Lipid Raft-Like Detergent-Resistant Membranes of Lens Fiber Cells |
Q36356545 | Pyroglutamate-Modified Amyloid-β(3-42) Shows α-Helical Intermediates before Amyloid Formation |
Q36149981 | Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II. |
Q55365663 | Strikingly different effects of cholesterol and 7-ketocholesterol on lipid bilayer-mediated aggregation of amyloid beta (1-42). |
Q92442501 | The Interaction between Amyloid Prefibrillar Oligomers of Salmon Calcitonin and a Lipid-Raft Model: Molecular Mechanisms Leading to Membrane Damage, Ca2+-Influx and Neurotoxicity |
Q52651588 | The on-fibrillation-pathway membrane content leakage and off-fibrillation-pathway lipid mixing induced by 40-residue β-amyloid peptides in biologically relevant model liposomes. |
Q57810644 | Thermodynamic, structural and functional properties of membrane protein inclusion bodies are analogous to purified counterparts: case study from bacteria and humans |
Q42628806 | Total Synthesis of the Aminopropyl Functionalized Ganglioside GM(1). |
Q51730305 | Toxic HypF-N Oligomers Selectively Bind the Plasma Membrane to Impair Cell Adhesion Capability. |
Q36238193 | Two-step mechanism of membrane disruption by Aβ through membrane fragmentation and pore formation |